Back
Marker Therapeutics, Inc. Stock Price Chart
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
61
MRKR
Marker Therapeutics, Inc.
Last Price:
$2.02
Seasonality Move:
11.17%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and MRKR is experiencing slight selling pressure.
Marker Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.91 | Buy |
| 20-day SMA: | 1.76 | Buy |
| 50-day SMA: | 1.4 | Buy |
| 200-day SMA: | 1.26 | Buy |
| 8-day EMA: | 1.97 | Buy |
| 20-day EMA: | 1.79 | Buy |
| 50-day EMA: | 1.52 | Buy |
| 200-day EMA: | 1.5 | Buy |
Marker Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 61.54 | Buy |
| Chaikin Money Flow: | -331335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.37 - 1.97) | Buy |
| Bollinger Bands (100): | (0.83 - 1.53) | Buy |
Marker Therapeutics, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics, Inc. Stock
Is Marker Therapeutics, Inc. Stock a Buy?
-
Marker Therapeutics, Inc. share price is 2.04 while MRKR 8-day simple moving average is 1.91, which is a Buy signal.
-
The stock price of MRKR is 2.04 while Marker Therapeutics, Inc. 20-day SMA is 1.76, which makes it a Buy.
-
Marker Therapeutics, Inc. 50-day simple moving average is 1.40 while MRKR share price is 2.04, making it a Buy technically.
-
MRKR stock price is 2.04 and Marker Therapeutics, Inc. 200-day simple moving average is 1.26, creating a Buy signal.
MRKR Technical Analysis vs Fundamental Analysis
Buy
61
Marker Therapeutics, Inc. (MRKR)
is a Buy
Is Marker Therapeutics, Inc. a Buy or a Sell?
-
Marker Therapeutics, Inc. stock is rated a BuyThe current Marker Therapeutics, Inc. [MRKR] share price is $2.04. The Score for MRKR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Marker Therapeutics, Inc. Stock Info
Market Cap:
33.3M
Price in USD:
2.04
Share Volume:
869.8K
Marker Therapeutics, Inc. 52-Week Range
52-Week High:
4.07
52-Week Low:
0.81
Buy
61
Marker Therapeutics, Inc. (MRKR)
is a Buy
Marker Therapeutics, Inc. Share Price Forecast
-
What is the Marker Therapeutics, Inc. stock price today?The Marker Therapeutics, Inc. stock price is 2.04 USD today.
-
Will MRKR stock go up or go down?Marker Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Marker Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics, Inc. is not overvalued.
Is Marker Therapeutics, Inc. Stock a Buy?
-
Marker Therapeutics, Inc. share price is 2.04 while MRKR 8-day exponential moving average is 1.97, which is a Buy signal.
-
The stock price of MRKR is 2.04 while Marker Therapeutics, Inc. 20-day EMA is 1.79, which makes it a Buy.
-
Marker Therapeutics, Inc. 50-day exponential moving average is 1.52 while MRKR share price is 2.04, making it a Buy technically.
-
MRKR stock price is 2.04 and Marker Therapeutics, Inc. 200-day simple moving average is 1.50, creating a Buy signal.
Fundamental Analysis of Marker Therapeutics, Inc.
Is Marker Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.35 per share.
Technical Analysis of Marker Therapeutics, Inc.
Should I short Marker Therapeutics, Inc. stock?
-
MRKR Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting Marker Therapeutics, Inc. is a Buy
-
Marker Therapeutics, Inc. Relative Strength Index (RSI) is 61.54, which suggest Marker Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Marker Therapeutics, Inc. is (1.37 - 1.97), which suggest Marker Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Marker Therapeutics, Inc. is (0.83 - 1.53), which suggest Marker Therapeutics, Inc. is a Buy
* Marker Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.